Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

BUY
$372.0 - $424.34 $1.22 Million - $1.39 Million
3,285 New
3,285 $1.35 Million
Q1 2023

Apr 26, 2023

SELL
$174.31 - $239.52 $48,632 - $66,826
-279 Reduced 17.34%
1,330 $250,000
Q4 2022

Feb 09, 2023

BUY
$153.06 - $226.57 $246,273 - $364,551
1,609 New
1,609 $341,000
Q1 2022

May 11, 2022

SELL
$138.87 - $214.31 $1.06 Million - $1.64 Million
-7,668 Closed
0 $0
Q4 2021

Feb 08, 2022

BUY
$182.74 - $227.9 $1.4 Million - $1.75 Million
7,668 New
7,668 $1.67 Million
Q3 2021

Nov 09, 2021

SELL
$170.18 - $198.21 $2.39 Million - $2.79 Million
-14,061 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$158.62 - $194.3 $87,716 - $107,447
553 Added 4.09%
14,061 $2.48 Million
Q1 2021

May 11, 2021

SELL
$132.02 - $168.26 $98,222 - $125,185
-744 Reduced 5.22%
13,508 $2.22 Million
Q4 2020

Feb 05, 2021

BUY
$109.38 - $149.19 $589,886 - $804,581
5,393 Added 60.88%
14,252 $1.98 Million
Q3 2020

Nov 04, 2020

SELL
$92.95 - $130.61 $107,264 - $150,723
-1,154 Reduced 11.53%
8,859 $990,000
Q2 2020

Aug 06, 2020

BUY
$68.08 - $95.68 $6,603 - $9,280
97 Added 0.98%
10,013 $931,000
Q1 2020

May 06, 2020

BUY
$61.71 - $101.95 $14,501 - $23,958
235 Added 2.43%
9,916 $728,000
Q4 2019

Feb 07, 2020

SELL
$70.08 - $84.64 $17,449 - $21,075
-249 Reduced 2.51%
9,681 $814,000
Q3 2019

Nov 08, 2019

SELL
$62.38 - $85.89 $426,055 - $586,628
-6,830 Reduced 40.75%
9,930 $834,000
Q2 2019

Aug 06, 2019

BUY
$53.64 - $65.42 $8,689 - $10,598
162 Added 0.98%
16,760 $0
Q1 2019

May 10, 2019

BUY
$49.38 - $70.58 $131,153 - $187,460
2,656 Added 19.05%
16,598 $979,000
Q4 2018

Feb 06, 2019

BUY
$46.97 - $63.98 $12,212 - $16,634
260 Added 1.9%
13,942 $738,000
Q3 2018

Nov 08, 2018

SELL
$43.25 - $63.74 $105,140 - $154,951
-2,431 Reduced 15.09%
13,682 $820,000
Q2 2018

Aug 02, 2018

BUY
$34.03 - $45.46 $548,325 - $732,496
16,113 New
16,113 $693,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.8B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Jennison Associates LLC Portfolio

Follow Jennison Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.